Contact

All Stories

  1. EIF5A2 controls ovarian tumor growth and metastasis by promoting epithelial to mesenchymal transition via the TGFβ pathway

    Article • Cell & Bioscience, April 2021, Springer Science + Business Media

    Dr Peixin Dong

  2. Critical Roles of PIWIL1 in Human Tumors: Expression, Functions, Mechanisms, and Potential Clinical Implications

    Article • Frontiers in Cell and Developmental Biology, February 2021, Frontiers

    Dr Peixin Dong

  3. PD-L1 Is a Tumor Suppressor in Aggressive Endometrial Cancer Cells and Its Expression Is Regulated by miR-216a and lncRNA MEG3

    Article • Frontiers in Cell and Developmental Biology, December 2020, Frontiers

    Dr Peixin Dong

  4. Zinc regulates primary ovarian tumor growth and metastasis through the epithelial to mesenchymal transition

    Article • Free Radical Biology and Medicine, November 2020, Elsevier

    Dr Peixin Dong

  5. The Expression, Functions and Mechanisms of Circular RNAs in Gynecological Cancers

    Article • Cancers, June 2020, MDPI AG

    Dr Peixin Dong

  6. MicroRNA-361-Mediated Inhibition of HSP90 Expression and EMT in Cervical Cancer Is Counteracted by Oncogenic lncRNA NEAT1

    Article • Cells, March 2020, MDPI AG

    Dr Peixin Dong

  7. L1CAM Predicts Adverse Outcomes in Patients with Endometrial Cancer Undergoing Full Lymphadenectomy and Adjuvant Chemotherapy

    Article • Annals of Surgical Oncology, December 2019, Springer Science + Business Media

    Dr Peixin Dong

  8. Ovarian primary and metastatic tumors suppressed by survivin knockout or a novel survivin inhibitor

    Article • Molecular Cancer Therapeutics, September 2019, American Association for Cancer Research (AACR)

    Dr Peixin Dong

  9. MicroRNA-361: A Multifaceted Player Regulating Tumor Aggressiveness and Tumor Microenvironment Formation

    Article • Cancers, August 2019, MDPI AG

    Dr Peixin Dong

  10. Long noncoding RNA NEAT1 drives aggressive endometrial cancer progression via miR-361-regulated networks involving STAT3 and tumor microenvironment-related genes

    Article • Journal of Experimental & Clinical Cancer Research, July 2019, Springer Science + Business Media

    Dr Peixin Dong

  11. Exploring lncRNA-Mediated Regulatory Networks in Endometrial Cancer Cells and the Tumor Microenvironment: Advances and Challenges

    Article • Cancers, February 2019, MDPI AG

    Dr Peixin Dong

  12. Molecular-targeted therapies and precision medicine for endometrial cancer

    Article • Japanese Journal of Clinical Oncology, November 2018, Oxford University Press (OUP)

    Dr Peixin Dong

  13. Long Non-coding RNA NEAT1: A Novel Target for Diagnosis and Therapy in Human Tumors

    Article • Frontiers in Genetics, October 2018, Frontiers

    Dr Peixin Dong

  14. miR-203 inhibits ovarian tumor metastasis by targeting BIRC5 and attenuating the TGFβ pathway

    Article • Journal of Experimental & Clinical Cancer Research, September 2018, Springer Science + Business Media

    Dr Peixin Dong

  15. Tumor-Intrinsic PD-L1 Signaling in Cancer Initiation, Development and Treatment: Beyond Immune Evasion

    Article • Frontiers in Oncology, September 2018, Frontiers

    Dr Peixin Dong

  16. B7H3 As a Promoter of Metastasis and Promising Therapeutic Target

    Article • Frontiers in Oncology, July 2018, Frontiers

    Dr Peixin Dong

  17. Comparison of human papillomavirus genotyping and cytology triage, COMPACT Study: Design, methods and baseline results in 14 642 women

    Article • Cancer Science, May 2018, Wiley

    Dr Sharon J.B. Hanley, Dr Peixin Dong

  18. Control of PD-L1 expression by miR-140/142/340/383 and oncogenic activation of the OCT4–miR-18a pathway in cervical cancer

    Article • Oncogene, May 2018, Springer Science + Business Media

    Dr Peixin Dong

  19. miR-34a, miR-424 and miR-513 inhibit MMSET expression to repress endometrial cancer cell invasion and sphere formation

    Article • Oncotarget, April 2018, Impact Journals, LLC

    Dr Peixin Dong

  20. Lentiviral vector mediated-ASAP1 expression promotes epithelial to mesenchymal transition in ovarian cancer cells

    Article • Oncology Letters, January 2018, Spandidos Publications

    Dr Peixin Dong

  21. Knockout of MTF1 Inhibits the Epithelial to Mesenchymal Transition in Ovarian Cancer Cells

    Article • Journal of Cancer, January 2018, Ivyspring International Publisher

    Dr Peixin Dong

  22. Lentiviral CRISPR/Cas9 nickase vector mediated BIRC5 editing inhibits epithelial to mesenchymal transition in ovarian cancer cells

    Article • Oncotarget, November 2017, Impact Journals, LLC

    Dr Peixin Dong

  23. Musashi-2, a novel oncoprotein promoting cervical cancer cell growth and invasion, is negatively regulated by p53-induced miR-143 and miR-107 activation

    Article • Journal of Experimental & Clinical Cancer Research, October 2017, Springer Science + Business Media

    Dr Peixin Dong

  24. Enhancer of Zeste homolog 2 (EZH2) induces epithelial-mesenchymal transition in endometriosis

    Article • Scientific Reports, July 2017, Nature

    Dr Peixin Dong

  25. iASPP induces EMT and cisplatin resistance in human cervical cancer through miR-20a-FBXL5/BTG3 signaling

    Article • Journal of Experimental & Clinical Cancer Research, April 2017, Springer Science + Business Media

    Dr Peixin Dong

  26. KLF4 expression enhances the efficacy of chemotherapy drugs in ovarian cancer cells

    Article • Biochemical and Biophysical Research Communications, March 2017, Elsevier

    Dr Peixin Dong

  27. EZH2 inhibition suppresses endometrial cancer progression via miR-361/Twist axis

    Article • Oncotarget, February 2017, Impact Journals, LLC

    Dr Peixin Dong

  28. Lentiviral CRISPR/Cas9 vector mediated miR-21 gene editing inhibits the epithelial to mesenchymal transition in ovarian cancer cells

    Article • Journal of Cancer, January 2017, Ivyspring International Publisher

    Dr Peixin Dong

  29. Suppression of iASPP-dependent aggressiveness in cervical cancer through reversal of methylation silencing of microRNA-124

    Article • Scientific Reports, October 2016, Nature

    Dr Peixin Dong

  30. MiR-137 and miR-34a directly target Snail and inhibit EMT, invasion and sphere-forming ability of ovarian cancer cells

    Article • Journal of Experimental & Clinical Cancer Research, September 2016, Springer Science + Business Media

    Dr Peixin Dong

  31. Challenges in breast and cervical cancer control in Japan

    Article • The Lancet Oncology, September 2016, Elsevier

    Dr Peixin Dong

  32. HPV self-sampling in Japanese women: A feasibility study in a population with limited experience of tampon use

    Article • Journal of Medical Screening, July 2016, SAGE Publications

    Dr Sharon J.B. Hanley, Dr Peixin Dong

  33. Reactivation of epigenetically silenced miR-124 reverses the epithelial-to-mesenchymal transition and inhibits invasion in endometrial cancer cells via the direct repression of IQGAP1 expression

    Article • Oncotarget, April 2016, Impact Journals, LLC

    Dr Peixin Dong

  34. Reactivating p53 functions by suppressing its novel inhibitor iASPP: a potential therapeutic opportunity in p53 wild-type tumors

    Article • Oncotarget, August 2015, Impact Journals, LLC

    Dr Peixin Dong

  35. Molecular targets and targeted therapy

    Article • November 2014, Future Medicine

    Dr Peixin Dong

  36. Genetic model of endometrial carcinogenesis

    Article • November 2014, Future Medicine

    Dr Peixin Dong

  37. The impact of microRNA-mediated PI3K/AKT signaling on epithelial-mesenchymal transition and cancer stemness in endometrial cancer

    Article • Journal of Translational Medicine, August 2014, Springer Science + Business Media

    Dr Peixin Dong

  38. MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells

    Article • Oncotarget, August 2014, Impact Journals, LLC

    Dr Peixin Dong

  39. Distribution of Lymph Node Metastasis Sites in Endometrial Cancer Undergoing Systematic Pelvic and Para-Aortic Lymphadenectomy: A Proposal of Optimal Lymphadenectomy for Future Clinical Trials

    Article • Annals of Surgical Oncology, April 2014, Springer Science + Business Media

    Dr Peixin Dong

  40. Correction: microRNA 31 functions as an endometrial cancer oncogene by suppressing Hippo tumor suppressor pathway

    Article • Molecular Cancer, January 2014, Springer Science + Business Media

    Dr Peixin Dong

  41. microRNA 31 functions as an endometrial cancer oncogene by suppressing Hippo tumor suppressor pathway

    Article • Molecular Cancer, January 2014, Springer Science + Business Media

    Dr Peixin Dong

  42. Identification of KLF17 as a novel epithelial to mesenchymal transition inducer via direct activation of TWIST1 in endometrioid endometrial cancer

    Article • Carcinogenesis, November 2013, Oxford University Press (OUP)

    Dr Peixin Dong

  43. MicroRNA-106b modulates epithelial-mesenchymal transition by targeting TWIST1 in invasive endometrial cancer cell lines

    Article • Molecular Carcinogenesis, September 2013, Wiley

    Dr Peixin Dong

  44. Abstract 5293: Prognostic significance of miR-194 in endometrial cancer.

    Article • Cancer Research, April 2013, American Association for Cancer Research (AACR)

    Dr Peixin Dong

  45. Prognostic significance of miR-194 in endometrial cancer

    Article • Biomarker Research, January 2013, Springer Science + Business Media

    Dr Peixin Dong

  46. Emerging Therapeutic Biomarkers in Endometrial Cancer

    Article • BioMed Research International, January 2013, Hindawi Publishing Corporation

    Dr Peixin Dong

  47. Mutant p53 gain-of-function induces EMT through modulation of the miR-130b–ZEB1 axis

    Article • Oncogene, July 2012, Springer Science + Business Media

    Dr Peixin Dong

  48. New revised FIGO 2008 staging system for endometrial cancer produces better discrimination in survival compared with the 1988 staging system

    Article • Journal of Surgical Oncology, June 2012, Wiley

    Dr Peixin Dong

  49. MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1

    Article • Molecular Cancer, January 2011, Springer Science + Business Media

    Dr Peixin Dong

  50. Allopurinol Attenuates Oxidative Stress and Cardiac Fibrosis in Angiotensin II-Induced Cardiac Diastolic Dysfunction

    Article • Cardiovascular Therapeutics, October 2010, Wiley

    Dr Peixin Dong

  51. CARDIOPROTECTIVE EFFECTS OF GRANULOCYTE COLONY-STIMULATING FACTOR IN ANGIOTENSIN II-INDUCED CARDIAC REMODELLING

    Article • Clinical and Experimental Pharmacology and Physiology, March 2009, Wiley

    Dr Peixin Dong

  52. Elevated expression of p53 gain-of-function mutation R175H in endometrial cancer cells can increase the invasive phenotypes by activation of the EGFR/PI3K/AKT pathway

    Article • Molecular Cancer, January 2009, Springer Science + Business Media

    Dr Peixin Dong

  53. Silencing of IQGAP1 by shRNA inhibits the invasion of ovarian carcinoma HO-8910PM cells in vitro

    Article • Journal of Experimental & Clinical Cancer Research, November 2008, Springer Science + Business Media

    Dr Peixin Dong

  54. p53 dominant-negative mutant R273H promotes invasion and migration of human endometrial cancer HHUA cells

    Article • Clinical & Experimental Metastasis, July 2007, Springer Science + Business Media

    Dr Peixin Dong

  55. Overexpression and diffuse expression pattern of IQGAP1 at invasion fronts are independent prognostic parameters in ovarian carcinomas

    Article • Cancer Letters, November 2006, Elsevier

    Dr Peixin Dong